Literature DB >> 17325363

Development and evaluation of an efficient cell-culture system for Hepatitis E virus.

Toshinori Tanaka1, Masaharu Takahashi, Eiji Kusano, Hiroaki Okamoto.   

Abstract

Using a faecal suspension with high load of Hepatitis E virus (HEV) (2.0x10(7) copies ml-1, genotype 3), we developed an efficient cell-culture system for HEV in a hepatocarcinoma cell line (PLC/PRF/5). HEV progeny released in the culture medium were passaged five times successively in PLC/PRF/5 cells. The initial day of appearance and load of HEV detectable in the culture supernatant after inoculation were dependent on the titre of seed virus in the inoculum. When 6.4x10(4) copies of HEV were inoculated on monolayers of PLC/PRF/5 cells in six-well microplates, HEV RNA was first detected in the culture medium on day 14 post-inoculation and increased to 9.1x10(5) copies ml-1 on day 60. When 8.6x10(5) copies of HEV were inoculated, HEV RNA was initially detected on day 12 and reached the highest titre of 8.6x10(7) copies ml-1 on day 60. HEV incubated at temperatures higher than 70 degrees C did not grow in PLC/PRF/5 cells, while HEV incubated at 56 degrees C for 30 min was infectious. Convalescent serum samples with IgM-class HEV antibodies obtained from patients infected with HEV of genotype 1, 3 or 4 neutralized the genotype 3 virus, indicating that HEV antibodies are broadly cross-reactive. Serum samples obtained from patients 8.7 or 24.0 years after the onset of HEV infection also prevented the propagation of HEV in PLC/PRF/5 cells, suggesting the presence of long-lasting HEV antibodies with neutralizing activity in individuals with past HEV infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17325363     DOI: 10.1099/vir.0.82535-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  75 in total

1.  Adaptation of a genotype 3 hepatitis E virus to efficient growth in cell culture depends on an inserted human gene segment acquired by recombination.

Authors:  P Shukla; H T Nguyen; K Faulk; K Mather; U Torian; R E Engle; S U Emerson
Journal:  J Virol       Date:  2012-03-07       Impact factor: 5.103

2.  Hepatitis E Virus.

Authors: 
Journal:  Transfus Med Hemother       Date:  2009       Impact factor: 3.747

3.  Characterization of hepatitis E virus recombinant ORF2 proteins expressed by vaccinia viruses.

Authors:  Nereida Jiménez de Oya; Estela Escribano-Romero; Ana-Belén Blázquez; María Lorenzo; Miguel A Martín-Acebes; Rafael Blasco; Juan-Carlos Saiz
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

Review 4.  Small Animal Models of Hepatitis E Virus Infection.

Authors:  Tian-Cheng Li; Takaji Wakita
Journal:  Cold Spring Harb Perspect Med       Date:  2019-08-01       Impact factor: 6.915

5.  Long-term inactivation study of three enteroviruses in artificial surface and groundwaters, using PCR and cell culture.

Authors:  A M de Roda Husman; W J Lodder; S A Rutjes; J F Schijven; P F M Teunis
Journal:  Appl Environ Microbiol       Date:  2008-12-12       Impact factor: 4.792

6.  Development and characterization of a genotype 4 hepatitis E virus cell culture system using a HE-JF5/15F strain recovered from a fulminant hepatitis patient.

Authors:  Toshinori Tanaka; Masaharu Takahashi; Hideyuki Takahashi; Koji Ichiyama; Yu Hoshino; Shigeo Nagashima; Hitoshi Mizuo; Hiroaki Okamoto
Journal:  J Clin Microbiol       Date:  2009-04-15       Impact factor: 5.948

7.  Hepatitis E Virus.

Authors:  Georg Pauli; Johannes Blümel; Reinhard Burger; Christian Drosten; Albrecht Gröner; Lutz Gürtler; Margarethe Heiden; Martin Hildebrandt; Bernd Jansen; Horst Klamm; Thomas Montag-Lessing; Ruth Offergeld; Rainer Seitz; Uwe Schlenkrich; Volkmar Schottstedt; Hannelore Willkommen; Carl-Heinz Wirsing von König
Journal:  Transfus Med Hemother       Date:  2008-01-18       Impact factor: 3.747

8.  Synthetic rabbit-human antibody conjugate as a control in immunoassays for immunoglobulin M specific to hepatitis E virus.

Authors:  Kuo Zhang; Lunan Wang; Min Liu; Rui Zhang; Jinming Li
Journal:  Virol J       Date:  2010-05-20       Impact factor: 4.099

9.  Sources of hepatitis E virus genotype 3 in The Netherlands.

Authors:  Saskia A Rutjes; Willemijn J Lodder; Froukje Lodder-Verschoor; Harold H J L van den Berg; Harry Vennema; Erwin Duizer; Marion Koopmans; Ana Maria de Roda Husman
Journal:  Emerg Infect Dis       Date:  2009-03       Impact factor: 6.883

10.  Experimental infection of Balb/c nude mice with Hepatitis E virus.

Authors:  Fen Huang; Wen Zhang; Ga Gong; Congli Yuan; Yijia Yan; Shixing Yang; Li Cui; Jianguo Zhu; Zhibiao Yang; Xiuguo Hua
Journal:  BMC Infect Dis       Date:  2009-06-13       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.